Steroid responsive meningitis symptoms

  1. Encyclopædia Britannica articles are written in a neutral objective tone for a general audience.
  2. You may find it helpful to search within the site to see how similar or related subjects are covered.
  3. Any text you add should be original, not copied from other sources.
  4. At the bottom of the article, feel free to list any sources that support your changes, so that we can fully understand their context. (Internet URLs are the best.)

References: 1. Bikowski J, Pillai R, Shroot B. The position not the presence of the halogen in corticosteroids influences potency and side effects. J Drugs Dermatol . 2006;5(2):125-130. 2. Del Rosso J, Friedlander SF. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol . 2005; 53(1 Suppl 1):s50-s58. 3. US Food and Drug Administration NDA 017765. Promius Pharma, LLC, Princeton, NJ: Aug 1977. 4. Rosenthal AL. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis. Cutis . 1980;25(1):96-98. 5. Kircik LH. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay. J Drugs Dermatol . 2014;13(5):582-585. 6. Cloderm [package insert]. Princeton, NJ: Promius Pharma, LLC; 2017.

Steroid responsive meningitis symptoms

steroid responsive meningitis symptoms

Media:

steroid responsive meningitis symptomssteroid responsive meningitis symptomssteroid responsive meningitis symptomssteroid responsive meningitis symptomssteroid responsive meningitis symptoms

http://buy-steroids.org